Myeloperoxidase as an important predictor of cardiovascular risk in individuals with rheumatoid arthritis.
Montes EG, Mansani FP, de Oliveira Toledo Júnior A, Schafranski MD, Zardo BQ, Dos Santos FA, Grassiolli S, de Freitas Calixto L, da Costa RL, de Freitas Netto F, Vellosa JCR.
Montes EG, et al. Among authors: schafranski md.
Inflammopharmacology. 2021 Dec;29(6):1819-1827. doi: 10.1007/s10787-021-00892-x. Epub 2021 Nov 26.
Inflammopharmacology. 2021.
PMID: 34825303